Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days

Humana adds 1.2 million individual Medicare Advantage members as insurance unit posts operating loss

Humana's individual Medicare Advantage rolls grew to 6.46 million from 5.24 million, but its Insurance segment benefit ratio rose to 93.7% and the unit posted an operating loss. It raised its adjusted 2026 EPS floor to $9.50.

From Humana's third-quarter 2026 earnings releases, furnished to the SEC on Form 8-K Nov. 6, 2026
A Humana office building in Louisville, Ky., in 2008.
A Humana office building in Louisville, Ky., in 2008. File photo.Angry Aspie / Wikimedia Commons (CC BY 3.0)

Humana is growing quickly in Medicare Advantage, and the new members are costing it more, relative to their premiums, than the ones it already had.

Humana Inc. said Nov. 6 that its individual Medicare Advantage membership reached 6.46 million at Sept. 30, up from 5.24 million a year earlier, according to its detailed earnings release. Its Insurance segment benefit ratio rose to 93.7% from 91.1%, and the segment lost $303 million from operations, compared with income of $251 million a year earlier.

Why it matters: Humana said new individual Medicare Advantage members carry a higher average benefit ratio than members who stayed, and it also cited a Star Ratings revenue headwind for bonus year 2026 and less favorable reserve development. Even so, the 93.7% ratio came in better than management's guidance of "slightly above 94 percent," and the company raised its full-year adjusted earnings guidance to at least $9.50 a share from at least $9.00.

Revenue rose about 26% to $41.2 billion from $32.6 billion. Humana attributed the Insurance segment's growth mainly to Medicare membership gains and higher per-member premiums, driven by increased Medicare Advantage benchmark funding from CMS and a larger Part D direct subsidy under the Inflation Reduction Act, partly offset by the star ratings headwind.

The company reported GAAP earnings of $1.33 a share and an adjusted loss of 70 cents a share, compared with adjusted earnings of $3.24 a year earlier. Favorable prior-period reserve development was $67 million, compared with $275 million in the year-earlier quarter.

The guidance math

Humana said its adjusted guidance still anticipates a decline from 2025, when it earned $17.14 a share on an adjusted basis, because of the bonus year 2026 Star Ratings headwind, net of mitigation. Through nine months, adjusted EPS was $17.17. The release did not break out fourth-quarter expectations.

GAAP guidance rose to at least $15.09 a share from at least $6.52. That includes an $11.42-a-share benefit from noncash put/call valuation adjustments on minority interest investments tied to its primary care partnership, according to the company's reconciliation, including the reversal of a net put liability of about $1.2 billion connected to CenterWell Senior Primary Care's earlier joint ventures with Welsh, Carson, Anderson & Stowe.

Humana kept its full-year guidance for individual Medicare Advantage membership growth of about 25%, an Insurance segment benefit ratio of 92.75%, plus or minus 25 basis points, and revenue of at least $160 billion.

Membership, CenterWell and what comes next

Group Medicare Advantage rose to 728,300 from 569,800, and standalone prescription drug plan membership grew to 4.03 million from 2.45 million. Total medical membership was 18.0 million, up from 15.0 million. Medicaid membership grew by 103,600, or 7%, this year, which Humana attributed largely to the start of integrated programs for dual-eligible members in Michigan, Illinois and South Carolina.

CenterWell segment revenue rose to $7.16 billion from $5.88 billion, and CenterWell Senior Primary Care has added 146,800 patients this year, a 30% increase.

"We are also increasingly driving financial and operating performance toward being 'ahead' of our plan," Jim Rechtin, president and chief executive, said in the release.

In October, Humana announced a joint venture with HPS Investment Partners, a BlackRock subsidiary, that replaces CenterWell Senior Primary Care's ventures with Welsh, Carson, Anderson & Stowe; the deal closed in the fourth quarter, the company said. Humana expects to record a noncash initial option liability tied to the new venture, worth $2.14 a share in its guidance reconciliation, in the fourth quarter. Its releases did not say how its plans fared in CMS's 2027 Star Ratings, which will affect 2028 bonus payments.

Sara Montes de Oca is the Editor in Chief of Charted. She previously worked as a correspondent and producer in Washington, D.C., covering business, finance, and politics. Drafted with automated tools from the sources listed with this story and checked against them before publishing. How we report.

More Payers & Policy

More
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.